Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Mousseau

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biology|May 17, 2014
Strategies to Block HIV Transcription: Focus on Small Molecule Tat InhibitorsGuillaume Mousseau, Susana Valente
Current Pharmaceutical Design|June 24, 2017
Role of Host Factors on the Regulation of Tat-Mediated HIV-1 TranscriptionGuillaume Mousseau, Susana T Valente
Expert Review of Anti-Infective Therapy|November 20, 2015
Didehydro-Cortistatin A: a new player in HIV-therapy?Guillaume Mousseau, Susana T Valente
Epigenetics & Chromatin|April 18, 2019
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeatChuan Li, Guillaume Mousseau, Susana T Valente
Current Topics in Microbiology and Immunology|March 4, 2015
Targeting HIV transcription: the quest for a functional cureGuillaume Mousseau, Sonia Mediouni, Susana T Valente
Angewandte Chemie (International Ed. in English)|August 17, 2016
Cell-Permeable Peptides Containing Cycloalanine ResiduesHao Wu, Guillaume Mousseau, Sonia Mediouni, et al.
Viruses|October 14, 2011
Core as a novel viral target for hepatitis C drugsArthur Donny Strosberg, Smitha Kota, Virginia Takahashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2025
The human endogenous retroviral envelope HEMO protein interacts with BACE2: Novel partnership acquired in the primate lineageAnthony Béguin, Marianne Chasseriaud, Guillaume Hollaender, et al.
Mbio|July 9, 2015
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from LatencyGuillaume Mousseau, Cari F Kessing, Rémi Fromentin, et al.
Protein Expression and Purification|August 13, 2005
Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastorisValérie Sarramegna, Isabelle Muller, Guillaume Mousseau, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biology|May 17, 2014
Strategies to Block HIV Transcription: Focus on Small Molecule Tat InhibitorsGuillaume Mousseau, Susana Valente
Current Pharmaceutical Design|June 24, 2017
Role of Host Factors on the Regulation of Tat-Mediated HIV-1 TranscriptionGuillaume Mousseau, Susana T Valente
Expert Review of Anti-Infective Therapy|November 20, 2015
Didehydro-Cortistatin A: a new player in HIV-therapy?Guillaume Mousseau, Susana T Valente
Epigenetics & Chromatin|April 18, 2019
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeatChuan Li, Guillaume Mousseau, Susana T Valente
Current Topics in Microbiology and Immunology|March 4, 2015
Targeting HIV transcription: the quest for a functional cureGuillaume Mousseau, Sonia Mediouni, Susana T Valente
Angewandte Chemie (International Ed. in English)|August 17, 2016
Cell-Permeable Peptides Containing Cycloalanine ResiduesHao Wu, Guillaume Mousseau, Sonia Mediouni, et al.
Viruses|October 14, 2011
Core as a novel viral target for hepatitis C drugsArthur Donny Strosberg, Smitha Kota, Virginia Takahashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2025
The human endogenous retroviral envelope HEMO protein interacts with BACE2: Novel partnership acquired in the primate lineageAnthony Béguin, Marianne Chasseriaud, Guillaume Hollaender, et al.
Mbio|July 9, 2015
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from LatencyGuillaume Mousseau, Cari F Kessing, Rémi Fromentin, et al.
Protein Expression and Purification|August 13, 2005
Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastorisValérie Sarramegna, Isabelle Muller, Guillaume Mousseau, et al.
Pageof 2